Roberto Mignone sold $4.8M of Teva Pharmaceutical Industries Limited (TEVA)

Executed Nov 6 2025, disclosed Nov 10 2025, 4 days later.

Value, as filed

$4.8M

200,000 sh × $24.11

Executed

Nov 6 2025

the trade date, as filed

Disclosed

Nov 10 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Roberto Mignone Director profile →

Roberto Mignone (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $4.8M of TEVA (200,000 sh × $24.11, as filed), executed Nov 6 2025.

The name

TEVA

Teva Pharmaceutical Industries Limited TEVA · Healthcare · 56 filings in 24 months ticker →

Healthcare · Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Roberto Mignone in TEVA

TEVASALE Teva Pharmaceutical Industries Limited $2.3M
77,400 sh × $30.24
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $1.3M
50,000 sh × $26.03
Exec Nov 26 2025
Filed Dec 1 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $6.3M
286,000 sh × $22.01
Exec Dec 20 2024
Filed Dec 26 2024 · 5:30 PM ET †